[Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
N V
NV
Lebedeva
E V
EV
Khrapova
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D009530:Nicergoline / Q000008:administration & dosage*; D010431:Pentoxifylline / Q000008:administration & dosage*; D013805:Theobromine / Q000031:analogs & derivatives*; D014748:Vinca Alkaloids / Q000008:administration & dosage*
D004873:Ergolines; D014748:Vinca Alkaloids; C013983:vinpocetine; D009530:Nicergoline; D013805:Theobromine; D010431:Pentoxifylline
Primenenie sermiona, kavintona i trentala u bol'nykh s tserebrovaskuliarnymi zabolevaniiami.